# Alfuzosin Versus Placebo in Acute Urinary Retention

> **NCT00453908** · PHASE3 · TERMINATED · sponsor: **Sanofi** · enrollment: 160 (—)

## Conditions studied

- Urinary Retention

## Interventions

- **DRUG:** Alfuzosin

## Key facts

- **NCT ID:** NCT00453908
- **Lead sponsor:** Sanofi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2004-05
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 160 (—)
- **Why stopped:** The study was early terminated due to slow and difficult recruitment
- **Last updated:** 2007-08-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00453908

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00453908, "Alfuzosin Versus Placebo in Acute Urinary Retention". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00453908. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*